GlobeNewswire•10 minutes agoLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage9887.HK5.79%
Stocktwits•12 minutes agoNVDA Stock’s 7-Day Losing Streak Sets Up Make-Or-Break AI Earnings Test: Retail Expects Yet Another Beat